While some states ban insurers from using copay accumulator programs, oversight has stalled at the federal level.

Clinician-led engagement outperforms non-clinical call-center models, with “nurse ambassador” programs enabling escalation, ...

Patients who rely on co-pay assistance from drugmakers are typically heavy users of health care for whom delays in treatment ...

The 340B program helps rural hospitals like Cookeville Regional provide affordable care to vulnerable patients.

Pervasive "unsustainable" clinical practices amid cat-and-mouse game with funding availabi ...

The emergence of Lilly’s bundling strategy for Zepbound and Taltz reflects the unregulated state of patient assistance programs in the commercial market and the need for Congressional intervention. A ...